Fosamax Esophageal Cancer Lawsuits
Fosamax (alendronate) is an oral bisphosphonate prescribed to treat osteoporosis, a condition which makes the bones brittle and prone to breaks.
While Fosamax and other bisphosphonates are beneficial in the treatment of osteoporosis, Paget’s disease, and other bone diseases, this potentially dangerous drug has been linked to a heightened incidence of esophageal cancer and other Fosamax side effects.
If you or a loved one has been diagnosed with esophageal cancer after taking Fosamax or another osteoporosis medication, you may be entitled to collect significant compensation in a pharmaceutical product liability lawsuit. Lawyers at Kelley Law Group, P.C. who experienced in this type of litigation are currently reviewing cases and can offer you a free legal consultation.
For more information, contact us today at 888-554-2889. We offer:
- No-obligation, no-fee initial consultations with a Fosamax attorney
- Help for Fosamax esophageal cancer victims nationwide
- Flexible scheduling
- No legal costs or fees unless you win your case
About Esophageal Cancer
The esophagus is the tube that connects the throat to the stomach. When food has been chewed, the esophagus contracts in a process called peristalsis to move that food to the stomach. When the cells in a person’s esophagus form tumors and reproduce without control, that person likely has esophageal cancer. The two main types of esophageal cancer are:
- Squamous cell carcinoma: This type of cancer is characterized by tumors that arise in squamous cells in esophagus lining. Squamous cell carcinoma affects the upper-middle part of the esophagus.
- Adenocarcinoma: With this type of esophageal cancer, tumors grow on the glandular tissue where the esophagus meets the stomach, in the lower part of the esophagus.
Treatment for esophageal cancer is dependent on the size and location of tumors, but generally includes chemotherapy and radiation. There is a 17% average five-year survival rate for esophageal cancer patients.
Fosamax and Esophageal Cancer
When a person takes Fosamax, there is a chance that small particles of the drug will become lodged in the esophagus, and this could lead to esophageal cancer. Right now, the FDA is reviewing data from a number ofrespected studies to evaluate the potential link between Fosamax and other bisphosphonates and esophageal cancer. In an FDA Drug Safety Communication released in July of 2011, the agency stated that tests to link Fosamax to esophageal cancer have been inconclusive to date. However, by 2009, the FDA had received up to 23 reports of esophageal cancer in U.S. Fosamax users. At this time, 8 Fosamax users had died of the cancer. In a 2010 study published in the British Journal of Medicine, researchers reported that use of Fosamax or another bisphosphonate for more than 5 years can double the risk of esophageal cancer.
If you have been diagnosed with esophageal cancer after taking Fosamax or another bisphosphonate such as Actonel, Boniva, Atelvia, Skelid, or Didronel, you may be owed substantial compensation. Compensation from a Fosamax lawsuit can help victims and their families focus on treatment by alleviating worries about medical bills, lost wages, and other damages. To learn more about pharmaceutical product liability litigation and your potential right to compensation, contact an experienced personal injury lawyer today.